State Of Wyoming Krystal Biotech, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$48.93 - $73.47 $33,663 - $50,547	-688 Reduced 90.89%	69 $5,000
Q1 2022 May 13, 2022	BUY	$51.99 - $72.11 $12,685 - $17,594	244 Added 47.56%	757 $50,000
Q4 2021 Feb 11, 2022	BUY	$39.81 - $88.24 $2,945 - $6,529	74 Added 16.86%	513 $36,000
Q3 2021 Feb 11, 2022	SELL	$52.01 - $71.77 $13,314 - $18,373	-256 Reduced 36.83%	439 $23,000
Q2 2021 Feb 11, 2022	BUY	$62.14 - $81.82 $28,895 - $38,046	465 Added 202.17%	695 $47,000
Q1 2021 Feb 08, 2022	BUY	$59.42 - $85.46 $13,666 - $19,655	230 New	230 $18,000

310

24.4M

483K

364K

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.57B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.